Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies

by Dunne, Michael W, Sahm, Dan, Puttagunta, Sailaja
Published 2015

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects

by Scoble, Patrick J., Owens, Robert C., Puttagunta, Sailaja, Yen, Mark, Dunne, Michael W.
Published 2015

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

by Dunne, Michael W., Puttagunta, Sailaja, Giordano, Philip, Krievins, Dainis, Zelasky, Michael, Baldassarre, James
Published 2016

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies

by Dunne, Michael W., Talbot, George H., Boucher, Helen W., Wilcox, Mark, Puttagunta, Sailaja
Published 2015

Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trial...

by Sagara, Issaka, Oduro, Abraham R, Mulenga, Modest, Dieng, Yemou, Ogutu, Bernhards, Tiono, Alfred B, Mugyenyi, Peter, Sie, Ali, Wasunna, Monique, Kain, Kevin C, Djimdé, Abdoulaye A, Sarkar, Shirsendu, Chandra, Richa, Robbins, Jeffery, Dunne, Michael W
Published 2014